top of page

Fresh Updates

Nutaria was selected among the top 50 European companies to participate in the prestigious EIT FAN Food-tech accelerator program. Nutaria was accepted to the food as medicine program at the Technion, Israel's Institute of Technology. The program participants will get mentorship from leading corporate and specialist in the food tech industry.

Nutaria - eit-food

We are proud to take part in the biomed 2023 convention taking place at the David intercontinental hotel in Tel Aviv on May 18th.

Our presentation will explore novel solutions in targeted delivery of functional food to various nutritional needs, focusing on cognitive and brain health support.

See you there !

Abstract Linear Background
Mind blowing results from Nutaria’s first in vitro POC demonstrated project.
vitro POC demonstrated project

More innovative models from Nutaria are coming together in collaboration with UNICA’s phytochemical research center.

Nutaria & UNICA

More Updates

At Nutaria, we are dedicated to pushing the boundaries of what is possible in the food industry through our innovative technology and commitment to excellence. Our targeted approach to developing functional food technologies can transform how people approach nutrition and wellness.

Israe Innovation Authority
IFF & DuPont

In May 2021, Nutaria was accepted to the prestigious innovation Lab program at IFF-DuPont's Israel food tech incubator.


The Israeli Innovation Authority supports this incubator, a harboring facility for Israel's future food tech industry startups.


This recognition by IFF DuPont, which is a major international player in food ingredients, is a source of pride for Nutaria.

In November of last year (2022), Nutaria was selected as one of Europe's top 10 most promising food tech companies, recognized for our innovative approach to developing functional food technologies.

Top 10 Food Tech Challengers 2023

In September 2022, we achieved a major milestone by demonstrating the effectiveness of our proprietary targeted technology platform. Third-party testing conducted by a CRO showed that our targeted nutraceuticals successfully bound to human neuronal cell assays, showcasing the incredible potential of our approach.

bottom of page